Immune evasion and therapeutic opportunities based on natural killer cells.

Zhang, Jinjin; Guo, Feifei; Li, Lingyu; Zhang, Songling; Wang, Yufeng

Zhang, Jinjin; Guo, Feifei; Li, Lingyu; Zhang, Songling; Wang, Yufeng.

Afiliación

Zhang J; Cancer Center, The First Hospital of Jilin University, Changchun 130021, China.
Guo F; Department of Gynecology, Obstetrics and Gynecology Center, The First Hospital of Jilin University, Changchun 130021, China.
Li L; Cancer Center, The First Hospital of Jilin University, Changchun 130021, China.
Zhang S; Cancer Center, The First Hospital of Jilin University, Changchun 130021, China.
Wang Y; Department of Gynecological Oncology, Obstetrics and Gynecology Center, The First Hospital of Jilin University, Changchun 130021, China.

Chin J Cancer Res ; 35(3): 283-298, 2023 Jun 30.

Article en En | MEDLINE | ID: mdl-37440830

Palabras clave

Immune evasion; NKG2D; PD-1; combination therapy; natural killer cell

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Chin J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google